3Arnold FW,Summersgill JT,Lajoie AS,et al.A worldwide perspective of atypical pathogens in community-acquired pneumonia.Am J Respir Crit Care Med,2007,175 (10):1086-1093.
4Vervloet LA,Marguet C,Camargos PA.Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community acquired pneumonias.Braz J Infect Dis,2007,11 (5):507-514.
5Lee KY.Pediatric Respiratory infections by Mycoplasma pneumoniae.Expert Rev Anti Infect Ther,2008,6(4):509-521.
6Korppi M,Heiskanen-Kosma T,Kleemola M.Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae:serological results of a prospective,populationbased study in primary health care.Respirology,2004,9 (1):109-114.
7Defilippi A,Silvestri M,Tacchella A,et al.Epidemiology and clinical features of Mycoplasma pneumoniae infection in children.Respir Med,2008,102(12):1762-1768.
8Kannan TR,Baseman JB.ADP-ribosylating and vacuolating cytotoxin of mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.Proc Natl Acad Sci USA,2006,103 (17):6724-6729.
